Global pharmaceutical companies Genentech, Biogen and Hoffmann-La Roche filed a patent infringement lawsuit against Dr. Reddy’s Laboratories in federal court Friday alleging the defendants plan to release a “copycat” of Rituxan, their rheumatoid arthritis and non-Hodgkin lymphoma-treating medication.
This complaint was first surfaced by Law.com Radar.